6N1V image
Deposition Date 2018-11-12
Release Date 2019-07-24
Last Version Date 2024-11-06
Entry Detail
PDB ID:
6N1V
Keywords:
Title:
Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.00 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:A12V163-a.01 Heavy chain
Chain IDs:A (auth: 3), I (auth: 1), S (auth: H)
Chain Length:225
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:A12V163-a.01 Light chain
Chain IDs:B (auth: 4), J (auth: 2), T (auth: L)
Chain Length:215
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp120
Gene (Uniprot):env
Chain IDs:C (auth: B), K (auth: A), Q (auth: C)
Chain Length:473
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Chain IDs:D (auth: F), L (auth: E), R (auth: D)
Chain Length:153
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:PGT122 Heavy chain
Chain IDs:E (auth: Y), M (auth: X), U (auth: M)
Chain Length:132
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:PGT122 Light chain
Chain IDs:F (auth: a), N (auth: Z), V (auth: N)
Chain Length:473
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:VRC03 Heavy chain
Chain IDs:G (auth: g), O (auth: f), W (auth: Q)
Chain Length:129
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:VRC03 Light chain
Chain IDs:H (auth: i), P (auth: h), X (auth: R)
Chain Length:225
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation

Abstact

The vaccine-mediated elicitation of antibodies (Abs) capable of neutralizing diverse HIV-1 strains has been a long-standing goal. To understand how broadly neutralizing antibodies (bNAbs) can be elicited, we identified, characterized, and tracked five neutralizing Ab lineages targeting the HIV-1-fusion peptide (FP) in vaccinated macaques over time. Genetic and structural analyses revealed two of these lineages to belong to a reproducible class capable of neutralizing up to 59% of 208 diverse viral strains. B cell analysis indicated each of the five lineages to have been initiated and expanded by FP-carrier priming, with envelope (Env)-trimer boosts inducing cross-reactive neutralization. These Abs had binding-energy hotspots focused on FP, whereas several FP-directed Abs induced by immunization with Env trimer-only were less FP-focused and less broadly neutralizing. Priming with a conserved subregion, such as FP, can thus induce Abs with binding-energy hotspots coincident with the target subregion and capable of broad neutralization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures